Clinical Scorecard: MS gray matter atrophy is associated with brain network architecture
At a Glance
| Category | Detail |
|---|---|
| Condition | Clinical topic addressed by the source article: MS gray matter loss reveals network-based mechanisms |
| Key Mechanisms | The study assessed nodal stress, transneuronal degeneration, lesion-related disconnection, and transcriptomic vulnerability. Cross-sectionally, atrophy was most strongly associated with tissue loss in structurally connected neighboring regions; lesion-related disconnection and transcriptomic similarity were not significantly associated with atrophy in primary cross-sectional analyses. Both were associated with subsequent atrophy in longitudinal analyses. |
| Target Population | Patients or participants described in the source article. |
| Care Setting | Care setting described in the source article. |
Key Highlights
- Structural connectivity–weighted neighboring atrophy correlated more strongly with cortical atrophy than functional connectivity–weighted neighboring atrophy (0.51 vs. 0.41).
- Functional hub characteristics were associated with greater cortical atrophy, while structural network hubness was not significantly associated with regional atrophy.
- In primary cross-sectional analyses, lesion-related disconnection and transcriptomic similarity were not significantly associated with cortical or subcortical atrophy.
- A longitudinal model incorporating network measures explained about 30% of the deviance in subsequent regional gray matter atrophy; adding network measures improved model fit.
- The authors noted that network-based correlations are indirect measures and do not establish causal disease propagation along neural pathways.
Guideline-Based Recommendations
Diagnosis
- Study methods: MRI was used to assess cortical thickness in 100 cortical regions and volumes in 14 additional brain structures.
Management
- The study did not report management recommendations.
Monitoring & Follow-up
- Longitudinal imaging was available for 565 patients, with a mean follow-up of 3.48 years.
Risks
- The predominantly cross-sectional design limits causal interpretation of observed associations.
- The study used normative rather than patient-specific connectivity data; the authors called for further studies with patient-specific connectivity measurements and repeated imaging.
Patient & Prescribing Data
The cohort included 1,963 participants with MS or clinically isolated syndrome and 224 healthy controls; mean age was 45.3 years and mean disease duration was 14.5 years.
The article reports imaging associations and atrophy patterns, not treatment or prescribing outcomes.
Clinical Best Practices
- The authors noted that network-based correlations are indirect measures and do not establish causal disease propagation along neural pathways.
- The authors noted limited representation of early MS and potential sensitivity limitations for deep gray matter structures.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
